When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...
You’re never too young to make a difference. Zachery Hunter has been working with Parkinson’s In Motion, a local 501©(3) ...
Techno-Science on MSN3h
🧬 Treating depression, obesity, or Parkinson's with magnets: a troubling experiment 🧲By controlling the neural circuits linked to Parkinson's disease, they observed a significant improvement in movement. The ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
AC Immune SA has reported encouraging interim results from its phase 2 VacSYn clinical trial of ACI-7104.056, an ...
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback